Cardio-immuno-oncology in cardiac tumors and cardiac metastases: immune microenvironment, therapeutic opportunities, and cardiotoxicity
Hao He, Jianyu Xiong, Junxiang Wang, Jianglin Wang, Jiayao Li, Zhongxiao Lin · 2026
Read Cardio-immuno-oncology in cardiac tumors and cardiac metastases: immune microenvironment, therapeutic opportunities, and cardiotoxicity by Hao He, Jianyu Xiong, Junxiang Wang, Jianglin Wang, Jiayao Li, Zhongxiao Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13631725.txt.
Description
Hao He and five co-authors review what immune cells do in cardiac tumors and in cancers that spread to the heart. True heart tumors are rare, while spread to the heart is more common in advanced cancer. Their 2026 review spans the immune landscape of both, the tricks tumors use to evade immunity, and the chances for immune-based care.
One benign heart tumor, the myxoma, shows inflammation signs and may take immune tuning of its own. Malignant heart tumors sit in immune-poor niches rich in macrophages, with worn-out T cells and mixed luck from checkpoint inhibitors. Spread cases may take such care with close heart monitoring. New tools — single-cell reads, place maps, and multi-omics — chart each tumor's immune landscape. Heart harm from the care itself, above all inflammation of the heart muscle, needs baseline checks and joint monitoring.
Catalog record
| CREATOR | Hao He, Jianyu Xiong, Junxiang Wang, Jianglin Wang, Jiayao Li, Zhongxiao Lin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |